Synthesis of PNU-95666E

Current Opinion in Drug Discovery and Development

Volumn 2, Issue 6, 1999, Pages 557-564

  Wuts, Peter G M ^a  

^a PFIZER INC   (United States)

Author keywords

Aziridine formation; Edman degradation; Jacobsen epoxidation; Scale up synthesis

Indexed keywords

8 QUINOLINOL; AZIRIDINE; DEXTRO PHENYLALANINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; IMIDAZOQUINOLINE DERIVATIVE; QUINOLINE DERIVATIVE; SUMANIROLE; UNCLASSIFIED DRUG;

CHEMICAL REACTION; DRUG MANUFACTURE; DRUG STRUCTURE; DRUG SYNTHESIS; EPOXIDATION; PARKINSON DISEASE; REVIEW;

EID: 0032714740     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Seeman P, Niznik HB: Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J (1990) 4(10):2737-2744.
2. Coleman RJ: Current drug therapy for Parkinson's disease. A review. Drugs Aging (1992) 2(2):112-124.
3. Heier RF, Dolak LA, Duncan JN, Hyslop DK, Upton MF, Martin IJ, Mauragis MA, Piercey MF, Nichds NF, Schreur PJ, Smith MW, Moon MW: Synthesis and biological activities. of (R}-5,6dihydro-N,/V-dimethyl-4H-imidazo[4,5,1-//]quinolin-5-amine and its metabolites. J Med Chem (1997) 40(5):639-646.
4. Moon MW, Morris JK, Heier RF, Chidester CG, Hoffmann WE, Piercey MF, Althaus JS, VonVoigtlander PF, Evans DL, Figur LM, Lahti RA: Dopaminergic and serotonergic activities of imidazoquinolinones and related compounds. J Med Chem (1992)35(6):1076-1092.
5. Moon MW, Hsi RS: Synthesis of tritium-labeled (R)-5(di[2,3-IHJpropylamino)-5,6-dihydro-4H-imidazo[4,5,1-/;] quinolin-2(1H)-one (['H1U-86170) and (R)-5-([2,3>HJpropylamino)-5,6-dihydru-4H-ImIdazo[4,5l1-//]quinolin2(1H)-one (['HJU-91356). J Label Compd Radiopharm (1992) 31(11):933-943.
6. Waller FJ, Barrett AG, Braddock DC, McKinnell RM, Ramprasad D: Lanthanide(lll) and Group IV metal triflate catalysed electrophilic nitration: 'nitrate capture' and the role of the metal centre. J Chem Soc Perkin Trans 1 (1999) 8:867-872.
7. Waller FJ, Barrett AG, Braddock DC, Ramprasad D, McKinnell RM, White AJ, Williams DJ, Ducray R: Tris(trifluoromethanesulfonyi)meth!de Ctriflide') anion: Convenient preparation, Xray crystal structures, and exceptional catalytic activity as a counter ion with ytterbium(lll) and scandium(lll). J Org Chem (1999)64(8):2910-2913.
8. Heier RF, Moon MW, Stolle WT, Easter JA, Hsi RS: An asymmetric synthesis of (R)-5,6-dihydro-5-(methylamino)4H-imidazo-[4,5,1-//]quinolin-2(1H)-one and its [2-"C]- and [6,7-'HJ-labeled forms. J Label Compd Radiopharm (1996) 38(12):1087-1098.
9. Jacobsen EN, Zhang W, Muci AR, Ecker JR, Deng L: Highly enantioselective epoxidation catalysts derived from 1,2diaminocyclohexane. J Am Chem Soc (1991) 113(18):70637064.
10. Moon MW, Morris JK, Heier RF, Hsi RS, Manis MO, Royer ME, Walters RR, Lawson CF, Smith MW, Lahti RA, Piercey MF, Sethy VH: Medicinal chemistry of imidazoquinolinone dopamine receptor agonists. Drug Des D;scov(1993)9(3-4):313-322.
11. Romero AG, Darlington WH, McMillan MW: Synthesis of the selective 0, receptor agonist PNU-95666E from Dphenylalanine using a sequential oxidative cyclization strategy. J Org Chem (1997) 62(19):6582-6587.
12. Punniyamurthy T, Miyafuji A, Katsuki T: Chlral Mn-salen catalyzed enantiotoplc selective C-H oxidation of mesopyrrolidine derivatives. Tetrahedron Lett (1998) 39(45):82958298.